Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash & Equivalents: 2016-2025

Historic Cash & Equivalents for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to $2.3 million.

  • cbdMD's Cash & Equivalents fell 7.80% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 7.80%. This contributed to the annual value of $2.3 million for FY2025, which is 7.80% down from last year.
  • As of FY2025, cbdMD's Cash & Equivalents stood at $2.3 million, which was down 7.80% from $2.5 million recorded in FY2024.
  • cbdMD's Cash & Equivalents' 5-year high stood at $26.4 million during FY2021, with a 5-year trough of $1.8 million in FY2023.
  • For the 3-year period, cbdMD's Cash & Equivalents averaged around $2.2 million, with its median value being $2.3 million (2025).
  • As far as peak fluctuations go, cbdMD's Cash & Equivalents surged by 78.16% in 2021, and later crashed by 74.56% in 2022.
  • cbdMD's Cash & Equivalents (MRY) stood at $26.4 million in 2021, then plummeted by 74.56% to $6.7 million in 2022, then tumbled by 73.25% to $1.8 million in 2023, then soared by 36.42% to $2.5 million in 2024, then fell by 7.80% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in FY2025, $2.5 million for FY2024, and $1.8 million during FY2023.